HEATHERENE CARLISLE: Open Payments
NPI 1104536796 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 16 payments from 9 companies in 2025. Trend: 2023 $1,863 · 2024 $277 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 4 | $77 |
| ABBVIE INC. | 3 | $64 |
| UCB, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $39 |
| Janssen Biotech, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $23 |
| Amgen Inc. | 1 | $17 |
| Radius Health, Inc. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: HADLIMA, RINVOQ, Bimzelx, XELJANZ, TREMFYA, TALTZ, TAVNEOS, Tymlos.
Industry payments across TX — which companies pay providers there.
